<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Alesta Therapeutics]]></title><description><![CDATA[A biotech company developing novel oral small molecule therapies for underserved rare diseases.]]></description><link>https://www.alestatherapeutics.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Wed, 27 May 2026 00:48:58 GMT</lastBuildDate><atom:link href="https://www.alestatherapeutics.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases]]></title><description><![CDATA[Alesta Therapeutics Secures €65 Million in Series A Funding to Develop Oral Small Molecules for Rare Diseases]]></description><link>https://www.alestatherapeutics.com/post/press-release-alesta-therapeutics-raises-65-million-series-a-financing-to-advance-oral-small-molec</link><guid isPermaLink="false">68ece68070ac46a609b7f64d</guid><pubDate>Wed, 08 Jan 2025 12:47:02 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/15981c_6976b4add1ab4e55b3c53bb3a0223210~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Karin Folman</dc:creator></item></channel></rss>